Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04CTP
|
||||
Former ID |
DIB006775
|
||||
Drug Name |
EP-200
|
||||
Synonyms |
HCG targeted oncolytic peptide (iv, CLYP, multiple cancers), Esperance Pharmaceuticals; Luteinizing hormone receptor targeted oncolytic peptide (iv/CLYP, multiple cancers), Esperance Pharmaceuticals
|
||||
Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543644] | ||
Company |
Esperance Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Lutropin-choriogonadotropic hormone receptor | Target Info | Modulator | [543644] | |
NetPath Pathway | FSH Signaling Pathway | ||||
Pathway Interaction Database | Arf6 signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.